课题基金 / 基金详情

Therapeutic approaches to treat human immunodeficiency virus infection: development of HIV-1 integrase inhibitors

Therapeutic approaches to treat human immunodeficiency virus infection: development of HIV-1 integrase inhibitors
治疗人类免疫缺陷病毒感染的治疗方法:HIV-1整合酶抑制剂的开发
批准号:
LP0775192
负责人:
Prof Martin Scanlon
金额:
$26.18万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Linkage Projects
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-19 至 2009-12-31

项目摘要

项目成果

Prof Martin Scanlon的其他基金

相似基金

相关文献

中文摘要
翻译
该项目旨在协助开发新的抗艾滋病毒药物,这将使目前感染这一可怕疾病的1.5万澳大利亚人和全世界4 000多万人受益。该项目将利用最先进的技术——包括2007年投入使用的澳大利亚同步加速器——来识别和合成化合物,作为治疗艾滋病毒的新先导。
英文摘要
This project aims to assist the development of new anti-HIV drugs, which would benefit the 15000 Australians and over 40 million people worldwide who are currently infected with this terrible disease. The project will utilise state of the art technologies - including the Australian Synchrotron when it is commissioned in 2007 - to identify and synthesise compounds as new leads for the treatment of HIV.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing new tools for chemical biology
  • 批准号:
    DP200100796
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $46.99万
  • 财政年份:
    2020
  • 负责人:
    Prof Martin Scanlon
  • 依托单位:
ARC Training Centre for the Development of Tools for Fragment Based Design
  • 批准号:
    IC180100021
  • 项目类别:
    Industrial Transformation Training Centres
  • 资助金额:
    $291.72万
  • 财政年份:
    2019
  • 负责人:
    Prof Martin Scanlon
  • 依托单位:
Distributed facility for fragment based drug discovery
  • 批准号:
    LE160100047
  • 项目类别:
    Linkage Infrastructure, Equipment and Facilities
  • 资助金额:
    $25.34万
  • 财政年份:
    2016
  • 负责人:
    Prof Martin Scanlon
  • 依托单位:
Structure-based design of inhibitors of HIV-1 integrase
  • 批准号:
    LP130100740
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $42.42万
  • 财政年份:
    2014
  • 负责人:
    Prof Martin Scanlon
  • 依托单位:
国内基金
海外基金
Lagrangian origin of geometric approaches to scattering amplitudes
  • 批准号:
    24ZR1450600
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    ALEXANDER OCHIROV
  • 依托单位: